Saikadatu, Halil .

HRN: 26-86-89  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2025
AMPICILLIN 250MG (VIAL)
04/04/2025
04/10/2025
IV
165mg
Q12
PROM
Waiting Final Action 
04/04/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
04/04/2025
04/10/2025
IV
50mg
Q24
PROM
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: